Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2013-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pbb.2013.03.016PMID 23567202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum brain‐derived neurotrophic factor levels were reduced during methamphetamine early withdrawal

  2014cited by this paper
• An Evaluation of the Evidence that Methamphetamine Abuse Causes Cognitive Decline in Humans

  2013cited by this paper
• Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression.

  2013cited by this paper
• 7,8‐dihydroxyflavone rescues spatial memory and synaptic plasticity in cognitively impaired aged rats

  2012cited by this paper
• Optimization of a small tropomyosin-related kinase B (TrkB) agonist 7,8-dihydroxyflavone active in mouse models of depression.

  2012cited by this paper
• Activation of TrkB by 7,8-Dihydroxyflavone Prevents Fear Memory Defects and Facilitates Amygdalar Synaptic Plasticity in Aging

  2012cited by this paper
• Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine

  2012cited by this paper
• 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's Disease

  2012cited by this paper
• Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration

  2012cited by this paper
• The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice.

  2012cited by this paper
• 7,8-Dihydroxyflavone exhibits anti-inflammatory properties by downregulating the NF-κB and MAPK signaling pathways in lipopolysaccharide-treated RAW264.7 cells.

  2012cited by this paper
• Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice.

  2011cited by this paper
• Antioxidant activity of 7,8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity.

  2011cited by this paper
• The Role of BDNF/TrkB Signaling in Acute Amphetamine-Induced Locomotor Activity and Opioid Peptide Gene Expression in the Rat Dorsal Striatum

  2011cited by this paper
• Vulnerability to Depression: From Brain Neuroplasticity to Identification of Biomarkers

  2011cited by this paper
• Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning.

  2011cited by this paper
• A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect.

  2010cited by this paper
• Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence.

  2010cited by this paper
• A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone

  2010cited by this paper
• Pharmacological approaches to methamphetamine dependence: a focused review.

  2010cited by this paper
• The methamphetamine problem in the United States.

  2010cited by this paper
• Effects of D-amino acid oxidase inhibitor on the extracellular D-alanine levels and the efficacy of D-alanine on dizocilpine-induced prepulse inhibition deficits in mice

  2009cited by this paper
• Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine.

  2009cited by this paper
• Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors.

  2009cited by this paper
• A critique of the dopamine hypothesis of schizophrenia and psychosis.

  2009cited by this paper
• Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons

  2009cited by this paper
• Involvement of Pallidotegmental Neurons in Methamphetamine- and MK-801-Induced Impairment of Prepulse Inhibition of the Acoustic Startle Reflex in Mice: Reversal by GABAB Receptor Agonist Baclofen

  2008cited by this paper
• Methamphetamine Causes Microglial Activation in the Brains of Human Abusers

  2008cited by this paper
• Minocycline Attenuates Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Administration of the NMDA Receptor Antagonist Dizocilpine

  2007cited by this paper
• New research on methamphetamine abuse

  2007cited by this paper
• Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.

  2006cited by this paper
• Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.

  2005cited by this paper
• Social Isolation Stress Significantly Enhanced the Disruption of Prepulse Inhibition in Mice Repeatedly Treated with Methamphetamine

  2004cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine.

  2003cited by this paper
• Differential Effects of Direct and Indirect Dopamine Agonists on Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out Mice

  2002cited by this paper
• Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

  2001cited by this paper
• Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients.

  1999cited by this paper
• Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients.

  1994cited by this paper
• Relapse of paranoid psychotic state in methamphetamine model of schizophrenia.

  1992cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991cited by this paper
• Sensorimotor gating and schizophrenia. Human and animal model studies.

  1990cited by this paper
• Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

  1986cited by this paper
• The dopamine hypothesis of schizophrenia: focus on the dopamine receptor.

  1976cited by this paper
• Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

  1973cited by this paper

• Pharmacologically activating BDNF/TrkB signaling exerted rapid-acting antidepressant-like effects through improving synaptic plasticity and neuroinflammation

  2025influential citation
• The Antidepressant Action of Fluoxetine Involves the Inhibition of Dlx5/6 in Cortical GABAergic Neurons through a TrkB-Dependent Pathway

  2024influential citation
• 7,8-Dihydroxyflavone is a direct inhibitor of human and murine pyridoxal phosphatase

  2024cites this paper
• 7,8-Dihydroxyflavone is a direct inhibitor of pyridoxal phosphatase

  2024cites this paper
• Cognitive improving actions of tofacitinib in a mouse model of Alzheimer disease involving TNF-α, IL-6, PI3K-Akt and GSK-3β signalling pathway

  2022cites this paper
• Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders.

  2021cites this paper
• Whole body hypoxic preconditioning-mediated multiorgan protection in db/db mice via nitric oxide-BDNF-GSK-3β-Nrf2 signaling pathway

  2021influential citation
• TrkB agonist 7,8-dihydroxyflavone reverses an induced prepulse inhibition deficit selectively in maternal immune activation offspring: implications for schizophrenia

  2021cites this paper
• Natural Psychoplastogens As Antidepressant Agents

  2020cites this paper
• Sex-specific sensitivity to methamphetamine-induced schizophrenia-relevant behaviours in neuregulin 1 type III overexpressing mice

  2020cites this paper
• Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders.

  2020cites this paper
• Exploring the role and mechanisms of diallyl trisulfide and diallyl disulfide in chronic constriction-induced neuropathic pain in rats

  2020cites this paper
• Mineralocorticoid receptor antagonist‐mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF‐H2S‐Nrf2 signaling

  2020cites this paper
• Targeting the Neuronal Activity of Prefrontal Cortex: New Directions for the Therapy of Depression

  2020cites this paper
• 7,8‐Dihydroxyflavone blocks the development of behavioral sensitization to MDPV, but not to cocaine: Differential role of the BDNF‐TrkB pathway

  2019cites this paper
• Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings

  2019cites this paper
• 7,8-Dihydroxyflavone facilitates the action exercise to restore plasticity and functionality: Implications for early brain trauma recovery.

  2017cites this paper
• Current Status of Substance Abuse in East Asia and Therapeutic Prospects.

  2016cites this paper
• Depression-like phenotype by deletion of α7 nicotinic acetylcholine receptor: Role of BDNF-TrkB in nucleus accumbens

  2016cites this paper
• Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets

  2016influential citation
• Intake of 7,8-Dihydroxyflavone During Juvenile and Adolescent Stages Prevents Onset of Psychosis in Adult Offspring After Maternal Immune Activation

  2016cites this paper
• Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice

  2016cites this paper
• Prefrontal cortical BDNF: A regulatory key in cocaine- and food-reinforced behaviors.

  2016cites this paper
• Brain-Derived Neurotrophic Factor (BDNF): TrkB Signaling in Depression – Biomarker and Novel Therapeutic Target

  2016cites this paper
• Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation

  2015cites this paper
• Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine

  2015cites this paper
• 7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders.

  2015cites this paper
• BDNF–TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms

  2015cites this paper
• Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression

  2015influential citation
• Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist.

  2015cites this paper
• BDNF–TrkB signaling as a therapeutic target in neuropsychiatric disorders

  2014cites this paper
• Evaluation of presynaptic dopamine dynamics after: Toluene inhalation or TrkB receptor activation

  2014cites this paper
• Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia.

  2014cites this paper
• 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine

  2013cites this paper
• Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease

  2013cites this paper
• Small molecules activating TrkB receptor for treating a variety of CNS disorders.

  2013cites this paper
• Probing the ability of presynaptic tyrosine kinase receptors to regulate striatal dopamine dynamics.

  2013cites this paper